Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Rezaee, Fariba ^a   Rellick, Stephanie L ^a   Piedimonte, Giovanni ^a   Akers, Stephen M ^a   O'Leary, Heather A ^a   Martin, Karen ^a   Craig, Michael D ^a   Gibson, Laura F ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR;

ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CYTOLOGY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; METABOLISM; METHODOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL;

BONE MARROW CELLS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 79551510909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009690     Document Type: Article

References (69)

1. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237: 1154-1162.
2. Barbacid M, Lamballe F, Pulido D, Klein R (1991) The trk family of tyrosine protein kinase receptors. Biochim Biophys Acta 1072: 115-127.
3. Boissiere F, Faucheux B, Ruberg M, Agid Y, Hirsch EC (1997) Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp Neurol 145: 245-252.
4. Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 33: 199-227.
5. Aloe L, Bracci-Laudiero L, Bonini S, Manni L (1997) The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 52: 883-894.
6. Laudiero LB, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, et al. (1992) Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett 147: 9-12.
7. Raychaudhuri SP, Jiang WY, Farber EM (1998) Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 78: 84-86.
8. Aloe L, Skaper SD, Leon A, Levi-Montalcini R (1994) Nerve growth factor and autoimmune diseases. Autoimmunity 19: 141-150.
9. Aloe L, Probert L, Kollias G, Bracci-Laudiero L, Spillantini MG, et al. (1993) The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 9: 149-155.
10. DeKosky ST, Goss JR, Miller PD, Styren SD, Kochanek PM, et al. (1994) Upregulation of nerve growth factor following cortical trauma. Exp Neurol 130: 173-177.
11. Washiyama K, Muragaki Y, Rorke LB, Lee VM, Feinstein SC, et al. (1996) Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. Am J Pathol 148: 929-940.
12. Calza L, Giardino L, Aloe L (1997) NGF content and expression in the rat pituitary gland and regulation by thyroid hormone. Brain Res Mol Brain Res 51: 60-68.
13. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, et al. (1996) Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci U S A 93: 10955-10960.
14. Gordon MY, Goldman JM, Gordon-Smith EC (1983) Spatial and functional relationships between human hemopoietic and marrow stromal cells in vitro. Int J Cell Cloning 1: 429-439.
15. Gordon MY, Kearney L, Hibbin JA (1983) Effects of human marrow stromal cells on proliferation by human granulocytic (GM-CFC), erythroid (BFU-E) and mixed (Mix-CFC) colony-forming cells. Br J Haematol 53: 317-325.
16. Hirano T (1998) Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16: 249-284.
17. Kishimoto T (1989) The biology of interleukin-6. Blood 74: 1-10.
18. Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, et al. (1992) Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology 77: 330-337.
19. Khair OA, Devalia JL, Abdelaziz MM, Sapsford RJ, Tarraf H, et al. (1994) Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNFalpha and expression of ICAM-1 in cultured human bronchial epithelial cells. Eur Respir J 7: 2109-2116.
20. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, et al. (1988) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797-1801.
21. Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161: 6480-6486.
22. Ohshima S, Saeki Y, Mima T, Sasai M, Nishioka K, et al. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci U S A 95: 8222-8226.
23. Kishimoto T, Akira S, Taga T (1992) Interleukin-6 and its receptor: a paradigm for cytokines. Science 258: 593-597.
24. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, et al. (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73-76.
25. Noma T, Mizuta T, Rosen A, Hirano T, Kishimoto T, et al. (1987) Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines. Immunol Lett 15: 249-253.
26. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, et al. (1989) IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A 86: 7547-7551.
27. Rodriguez MC, Bernad A, Aracil M (2004) Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support. Blood 103: 3349-3354.
28. Faggioli L, Costanzo C, Donadelli M, Palmieri M (2004) Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochim Biophys Acta 1692: 17-24.
29. Markel TA, Wang M, Crisostomo PR, Manukyan MC, Poynter JA, et al. (2008) Neonatal stem cells exhibit specific characteristics in function, proliferation, and cellular signaling that distinguish them from their adult counterparts. Am J Physiol Regul Integr Comp Physiol 294: R1491-R1497.
30. Furuno T, Nakanishi M (2006) Neurotrophic factors increase tumor necrosis factor-alpha-induced nuclear translocation of NF-kappaB in rat PC12 cells. Neurosci Lett 392: 240-244.
31. May MJ, Ghosh S (1998) Signal transduction through NF-kappa B. Immunol Today 19: 80-88.
32. Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
33. Handel ML, McMorrow LB, Gravallese EM (1995) Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum 38: 1762-1770.
34. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484.
35. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KF (1998) Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med 158: 1585-1592.
36. Mattson MP, Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107: 247-254.
37. Schonhoff CM, Bulseco DA, Brancho DM, Parada LF, Ross AH (2001) The Ras-ERK pathway is required for the induction of neuronal nitric oxide synthase in differentiating PC12 cells. J Neurochem 78: 631-639.
38. Zhuang ZY, Xu H, Clapham DE, Ji RR (2004) Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24: 8300-8309.
39. Freund-Michel V, Bertrand C, Frossard N (2006) TrkA signalling pathways in human airway smooth muscle cell proliferation. Cell Signal 18: 621-627.
40. Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and-independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11: 297-305.
41. Matsuda H, Coughlin MD, Bienenstock J, Denburg JA (1988) Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci U S A 85: 6508-6512.
42. Kannan Y, Ushio H, Koyama H, Okada M, Oikawa M, et al. (1991) 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood 77: 1320-1325.
43. Kannan Y, Matsuda H, Ushio H, Kawamoto K, Shimada Y (1993) Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor. Int Arch Allergy Immunol 102: 362-367.
44. Hamada A, Watanabe N, Ohtomo H, Matsuda H (1996) Nerve growth factor enhances survival and cytotoxic activity of human eosinophils. Br J Haematol 93: 299-302.
45. Boyle MD, Lawman MJ, Gee AP, Young M (1985) Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 134: 564-568.
46. Kobayashi H, Mizisin AP (2001) Nerve growth factor and neurotrophin-3 promote chemotaxis of mouse macrophages in vitro. Neurosci Lett 305: 157-160.
47. Caneva L, Soligo D, Cattoretti G, De HE, Deliliers GL (1995) Immuno-electron microscopy characterization of human bone marrow stromal cells with anti-NGFR antibodies. Blood Cells Mol Dis 21: 73-85.
48. Simone MD, De SS, Vigneti E, Papa G, Amadori S, et al. (1999) Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol Oncol 17: 1-10.
49. Schuhmann B, Dietrich A, Sel S, Hahn C, Klingenspor M, et al. (2005) A role for brain-derived neurotrophic factor in B cell development. J Neuroimmunol 163: 15-23.
50. Li N, Yang H, Lu L, Duan C, Zhao C, et al. (2007) Spontaneous expression of neural phenotype and NGF, TrkA, TrkB genes in marrow stromal cells. Biochem Biophys Res Commun 356: 561-568.
51. Rabizadeh S, Oh J, Zhong LT, Yang J, Bitler CM, et al. (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261: 345-348.
52. Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV (1998) Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 18: 3273-3281.
53. Nakayama T, Mutsuga N, Tosato G (2007) Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis. J Natl Cancer Inst 99: 223-235.
54. Yu M, Zheng X, Witschi H, Pinkerton KE (2002) The role of interleukin-6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Toxicol Sci 68: 488-497.
55. Fattori E, Della RC, Costa P, Giorgio M, Dente B, et al. (1994) Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83: 2570-2579.
56. Bracci-Laudiero L, Aloe L, Caroleo MC, Buanne P, Costa N, et al. (2005) Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production. Blood 106: 3507-3514.
57. Piedimonte G (2003) Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr Infect Dis J 22: S66-S74.
58. Raychaudhuri SP, Raychaudhuri SK (2004) Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res 146: 433-437.
59. Rameshwar P, Zhu G, Donnelly RJ, Qian J, Ge H, et al. (2001) The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: an understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell. J Neuroimmunol 121: 22-31.
60. Nowicki M, Ostalska-Nowicka D, Kondraciuk B, Miskowiak B (2007) The significance of substance P in physiological and malignant haematopoiesis. J Clin Pathol 60: 749-755.
61. Nowicki M, Ostalska-Nowicka D, Konwerska A, Miskowiak B (2006) The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow. J Clin Pathol 59: 935-941.
62. Elenkov IJ (2008) Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 52: 40-51.
63. Yamaguchi M, Kojima T, Kanekawa M, Aihara N, Nogimura A, et al. (2004) Neuropeptides stimulate production of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in human dental pulp cells. Inflamm Res 53: 199-204.
64. Yamaguchi M, Ozawa Y, Mishima H, Aihara N, Kojima T, et al. (2008) Substance P increases production of proinflammatory cytokines and formation of osteoclasts in dental pulp fibroblasts in patients with severe orthodontic root resorption. Am J Orthod Dentofacial Orthop 133: 690-698.
65. Sio SW, Puthia MK, Lu J, Moochhala S, Bhatia M (2008) The neuropeptide substance P is a critical mediator of burn-induced acute lung injury. J Immunol 180: 8333-8341.
66. Scicchitano MS, McFarland DC, Tierney LA, Boyce RW, Frazier KS, et al. (2008) Role of p38 in regulation of hematopoiesis: effect of p38 inhibition on cytokine production and transcription factor activity in human bone marrow stromal cells. Blood Cells Mol Dis 40: 370-380.
67. Gibson LF, Fortney J, Landreth KS, Piktel D, Ericson SG, et al. (1997) Disruption of bone marrow stromal cell function by etoposide 3. Biol Blood Marrow Transplant 3: 122-132.
68. Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61: 364-370.
69. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25: 402-408.